Image analysis software developer Perspectum Diagnostics is expanding development of its artificial intelligence (AI) algorithm to include cardiac and lung imaging.
The company has launched two new studies: Coverscan and Modify. The studies involve aortic and cardiac imaging with MRI and are particularly aimed at better understanding the impact and progression of COVID-19 disease (Coverscan) and diabetes (Modify).
The studies are part of Perspectum's further development of its Atlas metabolic software suite, according to the firm.
